Comments
Loading...
Elevation Oncology (ELEV) Forecast
NewsEarningsElevation Oncology (ELEV) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestElevation Oncology (NASDAQ:ELEV) Stock Quotes, Forecast and News Summary
Elevation Oncology Stock (NASDAQ: ELEV) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Elevation Oncology (ELEV) stock?
You can purchase shares of Elevation Oncology (NASDAQ:ELEV) through any online brokerage.
Who are Elevation Oncology (ELEV) competitors?
Other companies in Elevation Oncology’s space includes: HOOKIPA Pharma (NASDAQ:HOOK), Estrella Immunopharma (NASDAQ:ESLA), Acurx Pharmaceuticals (NASDAQ:ACXP), CARISMA Therapeutics (NASDAQ:CARM) and Lumos Pharma (NASDAQ:LUMO).
What is the forecast, or price target, for Elevation Oncology (ELEV) stock?
Elevation Oncology has a consensus price target of $7.50.
What is the current price for Elevation Oncology (ELEV)?
The stock price for Elevation Oncology (NASDAQ: ELEV) is $0.5444 last updated November 18, 2024 at 1:01 PM EST.
Does Elevation Oncology (ELEV) pay a dividend?
There are no upcoming dividends for Elevation Oncology.
When is Elevation Oncology (NASDAQ:ELEV) reporting earnings?
Elevation Oncology’s Q3 earnings are confirmed for Wednesday, November 6, 2024.
Is Elevation Oncology (ELEV) going to split?
There is no upcoming split for Elevation Oncology.
What sector and industry does Elevation Oncology (ELEV) operate in?
Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.